Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
olokizumab (3 trials)
inactivated SARS-Cov-2 vaccine (1 trial)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Necrosis (Phase 3)
Trials (4 total)
Trial APIs (2 total)